These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24715519)

  • 1. Topological mapping of BRIL reveals a type II orientation and effects of osteogenesis imperfecta mutations on its cellular destination.
    Patoine A; Gaumond MH; Jaiswal PK; Fassier F; Rauch F; Moffatt P
    J Bone Miner Res; 2014 Sep; 29(9):2004-16. PubMed ID: 24715519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Osteogenesis Imperfecta Type V Mutant BRIL/IFITM5 Promotes Transcriptional Activation of MEF2, NFATc, and NR4A in Osteoblasts.
    Maranda V; Gaumond MH; Moffatt P
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor.
    Farber CR; Reich A; Barnes AM; Becerra P; Rauch F; Cabral WA; Bae A; Quinlan A; Glorieux FH; Clemens TL; Marini JC
    J Bone Miner Res; 2014 Jun; 29(6):1402-11. PubMed ID: 24519609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crispr-Cas9 engineered osteogenesis imperfecta type V leads to severe skeletal deformities and perinatal lethality in mice.
    Rauch F; Geng Y; Lamplugh L; Hekmatnejad B; Gaumond MH; Penney J; Yamanaka Y; Moffatt P
    Bone; 2018 Feb; 107():131-142. PubMed ID: 29174564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression.
    Reich A; Bae AS; Barnes AM; Cabral WA; Hinek A; Stimec J; Hill SC; Chitayat D; Marini JC
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E325-32. PubMed ID: 25387264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of bone material properties in growing Ifitm5/BRIL p.S42 knock-in mice, a new model for atypical type VI osteogenesis imperfecta.
    Hedjazi G; Guterman-Ram G; Blouin S; Schemenz V; Wagermaier W; Fratzl P; Hartmann MA; Zwerina J; Fratzl-Zelman N; Marini JC
    Bone; 2022 Sep; 162():116451. PubMed ID: 35654352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The osteogenic cell surface marker BRIL/IFITM5 is dispensable for bone development and homeostasis in mice.
    Patoine A; Husseini A; Kasaai B; Gaumond MH; Moffatt P
    PLoS One; 2017; 12(9):e0184568. PubMed ID: 28880886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nonclassical IFITM5 mutation located in the coding region causes severe osteogenesis imperfecta with prenatal onset.
    Hoyer-Kuhn H; Semler O; Garbes L; Zimmermann K; Becker J; Wollnik B; Schoenau E; Netzer C
    J Bone Miner Res; 2014 Jun; 29(6):1387-91. PubMed ID: 24293101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFITM5 mutations and osteogenesis imperfecta.
    Hanagata N
    J Bone Miner Metab; 2016 Mar; 34(2):123-31. PubMed ID: 26031935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model for transport of a viral membrane protein through the early secretory pathway: minimal sequence and endoplasmic reticulum lateral mobility requirements.
    Serra-Soriano M; Pallás V; Navarro JA
    Plant J; 2014 Mar; 77(6):863-79. PubMed ID: 24438546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bril: a novel bone-specific modulator of mineralization.
    Moffatt P; Gaumond MH; Salois P; Sellin K; Bessette MC; Godin E; de Oliveira PT; Atkins GJ; Nanci A; Thomas G
    J Bone Miner Res; 2008 Sep; 23(9):1497-508. PubMed ID: 18442316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two mutations in IFITM5 causing distinct forms of osteogenesis imperfecta.
    Guillén-Navarro E; Ballesta-Martínez MJ; Valencia M; Bueno AM; Martinez-Glez V; López-González V; Burnyte B; Utkus A; Lapunzina P; Ruiz-Perez VL
    Am J Med Genet A; 2014 May; 164A(5):1136-42. PubMed ID: 24478195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erv14p directs a transmembrane secretory protein into COPII-coated transport vesicles.
    Powers J; Barlowe C
    Mol Biol Cell; 2002 Mar; 13(3):880-91. PubMed ID: 11907269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteogenesis imperfecta without features of type V caused by a mutation in the IFITM5 gene.
    Grover M; Campeau PM; Lietman CD; Lu JT; Gibbs RA; Schlesinger AE; Lee BH
    J Bone Miner Res; 2013 Nov; 28(11):2333-7. PubMed ID: 23674381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the bone-restricted IFITM-like (Bril) gene transcription by Sp and Gli family members and CpG methylation.
    Kasaai B; Gaumond MH; Moffatt P
    J Biol Chem; 2013 May; 288(19):13278-94. PubMed ID: 23530031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topology and endoplasmic reticulum retention signals of the lysosomal storage disease-related membrane protein CLN6.
    Heine C; Quitsch A; Storch S; Martin Y; Lonka L; Lehesjoki AE; Mole SE; Braulke T
    Mol Membr Biol; 2007; 24(1):74-87. PubMed ID: 17453415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus.
    Semler O; Garbes L; Keupp K; Swan D; Zimmermann K; Becker J; Iden S; Wirth B; Eysel P; Koerber F; Schoenau E; Bohlander SK; Wollnik B; Netzer C
    Am J Hum Genet; 2012 Aug; 91(2):349-57. PubMed ID: 22863195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A brilliant breakthrough in OI type V.
    Lazarus S; Moffatt P; Duncan EL; Thomas GP
    Osteoporos Int; 2014 Feb; 25(2):399-405. PubMed ID: 24030286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual role of the cysteine-string domain in membrane binding and palmitoylation-dependent sorting of the molecular chaperone cysteine-string protein.
    Greaves J; Chamberlain LH
    Mol Biol Cell; 2006 Nov; 17(11):4748-59. PubMed ID: 16943324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V.
    Cho TJ; Lee KE; Lee SK; Song SJ; Kim KJ; Jeon D; Lee G; Kim HN; Lee HR; Eom HH; Lee ZH; Kim OH; Park WY; Park SS; Ikegawa S; Yoo WJ; Choi IH; Kim JW
    Am J Hum Genet; 2012 Aug; 91(2):343-8. PubMed ID: 22863190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.